Need for a guideline on the clinical development of thrombopoetin receptor agonists for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Current version

PDF iconConcept paper

Reference numberEMA/CHMP/EWP/203111/2010
Published03/06/2010
KeywordsChronic immnune idiopathic thrombocytopenic purpura, ITP, thrombopoeting agonists
DescriptionThis document reflects the need for a guideline on the evaluation of the safety and efficacy of thrombopoetin receptor agonists fin the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Topics

How useful was this page?

Add your rating